Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Effect of N-3 Polyunsaturated Fatty Acids on Lung Funktion and use of Medication in Athletes with Asthma. A pilot Trial.

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The Use of Acoustic MyoGraphy as a Measure of Training Effects in Athletes: A 10 Month Case Study of a BMX Rider

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The risk of asthma is increased among women with polycystic ovary syndrome: a twin study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Benralizumab for the Prevention of COPD Exacerbations

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Exposure to Vitamin D Fortification Policy in Prenatal Life and the Risk of Childhood Asthma: Results From the D-Tect Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. A systematic review of surgical treatment for supraglottic exercise-induced laryngeal obstruction

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations
Asthma is the most frequent chronic disease among young adulsts,not least in the western societies, with an even higher frequency among elite athletes. Asthma consists of airway inflammation and smooth muscle contraction, normally treated with anti-asthma therapy, some of which have side effects. n-3 LCPUFA in fish oil (FO) has anti-inflammatory effects, and some studies have shown clinical effects of FO on asthma. We aimed to study if FO has an anti-asthma effect in elite athletes with asthma.
The study was a rondomized, double-blinded clinical trial. Ten elite athletes with a medical certificate allowing the use of asthma medication, age 15-36 years, were requited among elite athletes supported by the Team Denmark Organization. All subjects had a positive mannitol test prior to enrollment. Depending on whether they used inhaled corticosteroids or not, the subjects were randomly assigned in pairs to either FO (2 g EPA nad 1.3 g DHA) or soy oil capules (O) for 8 weeks. Change in forced expiratory volume (FEV1) after exercise, NO excretion, sputum cell count and use of medication were measured before and after intervention.
The was a slight trend towards increased exercised-induced decrease in lung function, use of asthma medication and respiratory inflammation in the FO-group, but the changes wre neither significant nor clinically relevant.
Original languageEnglish
JournalAnnals of Sports Medicine and Research
Volume1 (2)
Issue number1009
Publication statusPublished - Dec 2014

ID: 44829599